Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Lupkynis and Covid

If this Lupkynis drug suppresses the production of the cytokine by the body why don't they use it in the treatment of the severe Covid cases when they have the "cytokine storm"?  rate and reply

RE:RE:Globe & Mail

Should be.....just waiting until they start selling and adding revenue. They seem to be on schedule.  rate and reply

Homerun Resources Inc. Announces Unit Financing at $0.10

Homerun is pleased to announce a non-brokered private placement financing for aggregate gross proceeds of up to $2,000,000. The financing will consist of up to twenty million units at 10 cents, each unit consisting of one common share of the company and one common share purchase warrant with each warrant being exercisable for an additional common share at an exercise price of 20 cents for 12 months more

RE:Globe & Mail

Just entered for the first time. Hope it will be a profitable ride!  rate and reply

Globe & Mail

06:11 AM EDT, 03/15/2021 (MT Newswires) -- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH and TSX: AUP) was at last look up about 3% in US pre-market after announcing a "favorable" more


link  rate and reply

RE:Projected Return

Projections are not looking good this week.  rate and reply

Projected Return

Top of the list. GLTA Listed below is a complete list of all 219 companies in the S&P/TSX composite index grouped by sector and ranked based on their expected price returns (excluding dividend more

RE:Shorts Still a Factor

Maybe its time to start a reddit post and squeeze those shorts....  rate and reply

Shorts Still a Factor

Although the value of short trades has been declining since the beginning of Feb, it  still accounts for 28% of the total trades. Now that we're into March, new numbers should be coming more


Yes I think they are in good shape.....the share price just doesn't want to go up.....I thought we would have more interest.  rate and reply


wrong with those earnings,170% increase on sales same period last year. Anyone can see PT's are double current SP. Lets see if we can get a squeeze going, bears have been choking this to death.  rate and reply

Short positions

Link LOL If anyone was watching Zacks came out with a article a while ago and with a sell rating on this stock. Then they shorted it to drop the price.  Then they accumulated and after put more

RE:More Upgrades

Took an partial position this morning .  rate and reply

Robert Foster started the 1 in 100s chance!

Watch why Voclosporin should be propelling AUP to over $100! Very, very few biotech companies succeed in getting to market. Dr. Robert Foster incorporated Isotechnika Pharma in 1993, where he more

Reason for action & jump today?

Up 7% today on good volume. Can anyone expound on the reason? Was a total disappointment that the FDA approval didn't make a greater, lasting SP improvement. Also, anyone know why more


More buying from another insider.  rate and reply

Globe & Mail

Royal Bank of Canada is backing the country’s largest life sciences venture capital fund in two decades, making it one of the few Bay Street institutions to invest in the surging domestic more


Buy, 900  @ 16.14  Stephen Robertson  rate and reply

Streetwise Reports

Aurinia Pharma Shares Open at 52-Week High as FDA Approves Adult Lupus Nephritis Drug   Source: more


Thanks for posting the detailed analysis.  Product sales estimates are roughly in line with what I was figuring.  I said I thought it wouldn't be over $25 Cdn on Monday and it closed more